Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study.
D000328:Adult; D000368:Aged; D000880:Anthraquinones / Q000009:adverse effects / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D003404:Creatinine / Q000097:blood; D004341:Drug Evaluation; D006801:Humans; D007958:Leukocyte Count; D008654:Mesothelioma / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D008942:Mitoxantrone; D010976:Platelet Count
D000880:Anthraquinones; D003404:Creatinine; D008942:Mitoxantrone; D001663:Bilirubin